Cart
sales@molnova.com
Oxypeucedanin hydrate
CAS No. 2643-85-8
Oxypeucedanin hydrate( —— )
Catalog No. M18330 CAS No. 2643-85-8
Oxypeucedanin hydrate exhibits carbohydrate metabolizing enzymes inhibitory effect.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 67 | In Stock |
|
| 5MG | 61 | In Stock |
|
| 10MG | 93 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameOxypeucedanin hydrate
-
NoteResearch use only, not for human use.
-
Brief DescriptionOxypeucedanin hydrate exhibits carbohydrate metabolizing enzymes inhibitory effect.
-
DescriptionOxypeucedanin hydrate has antioxidant activity. Oxypeucedanin hydrate is an antimutagenic agent. Oxypeucedanin hydrate exhibits carbohydrate metabolizing enzymes inhibitory effect.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayChromatin/Epigenetic
-
TargetEpigenetic Reader Domain
-
RecptorAntioxidant
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2643-85-8
-
Formula Weight304.29
-
Molecular FormulaC16H16O6
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (328.63 mM)
-
SMILESCC(C)(C(COC1=C2C=CC(=O)OC2=CC3=C1C=CO3)O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
RVX-208
RVX-208 is a potent BET bromodomain inhibitor with IC50 of 0.510 μM for BD2 in a cell-free assay, about 170-fold selectivity over BD1. Phase 2.
-
PBRM1-BD2-IN-2
PBRM1-BD2-IN-2, a selective and cell-active inhibitor of the polybromo-1 (PBRM1) bromodomain, exhibits binding affinity and inhibitory activity specifically targeting the PBRM1-BD2 domain, with Kd and IC50 values of 9.3 μM and 1.0 μM, respectively.
-
PBRM1-BD2-IN-5
PBRM1-BD2-IN-5 is a potent inhibitor of the PBRM1 Bromodomain, with dissociation constant (Kd) values of 1.5 μM and 3.9 μM for PBRM1-BD2 and PBRM1-BD5 respectively, and an inhibitory concentration 50 (IC50) value of 0.26 μM for PBRM1-BD2.
